| Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ... New England Journal of Medicine 385 (24), e83, 2021 | 853 | 2021 |
| BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ... Nature medicine 27 (12), 2136-2143, 2021 | 448 | 2021 |
| Protection against the Omicron variant from previous SARS-CoV-2 infection HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ... New England Journal of Medicine 386 (13), 1288-1290, 2022 | 409 | 2022 |
| Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ... New England Journal of Medicine 386 (19), 1804-1816, 2022 | 365 | 2022 |
| Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... Nature communications 13 (1), 3082, 2022 | 220 | 2022 |
| Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... The Lancet Microbe 3 (12), e944-e955, 2022 | 61 | 2022 |
| Severity, criticality, and fatality of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant LJ Abu-Raddad, H Chemaitelly, HH Ayoub, HM Yassine, FM Benslimane, ... Clinical Infectious Diseases 75 (1), e1188-e1191, 2022 | 59 | 2022 |
| Covid-19 vaccine protection among children and adolescents in Qatar H Chemaitelly, S AlMukdad, HH Ayoub, HN Altarawneh, P Coyle, P Tang, ... New England Journal of Medicine 387 (20), 1865-1876, 2022 | 48 | 2022 |
| Effects of BA. 1/BA. 2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections SH Qassim, H Chemaitelly, HH Ayoub, S AlMukdad, P Tang, MR Hasan, ... Journal of Travel Medicine 29 (6), taac068, 2022 | 47 | 2022 |
| Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant H Altarawneh, H Chemaitelly, P Tang, MR Hasan, S Qassim, HH Ayoub, ... MedRxiv, 2022.01. 05.22268782, 2022 | 43 | 2022 |
| Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Tang, MR Hasan, HM Yassine, ... medRxiv, 2022.02. 07.22270568, 2022 | 32 | 2022 |
| Economic evaluations of CYP2C19 genotype-guided antiplatelet therapy compared to the universal use of antiplatelets in patients with acute coronary syndrome: a systematic review S AlMukdad, H Elewa, D Al-Badriyeh Journal of cardiovascular pharmacology and therapeutics 25 (3), 201-211, 2020 | 29 | 2020 |
| Epidemiology of herpes simplex virus type 2 in Asia: a systematic review, meta-analysis, and meta-regression S AlMukdad, M Harfouche, A Wettstein, LJ Abu-Raddad The Lancet Regional Health–Western Pacific 12, 2021 | 20 | 2021 |
| Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar A Zaqout, MA Almaslamani, H Chemaitelly, SA Hashim, A Ittaman, ... International Journal of Infectious Diseases 124, 96-103, 2022 | 17 | 2022 |
| Status of the HIV epidemic in key populations in the Middle East and north Africa: knowns and unknowns GR Mumtaz, H Chemaitelly, S AlMukdad, A Osman, S Fahme, NA Rizk, ... The Lancet HIV 9 (7), e506-e516, 2022 | 16 | 2022 |
| All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic AA AlNuaimi, H Chemaitelly, S Semaan, S AlMukdad, Z Al-Kanaani, ... BMJ global health 8 (5), e012291, 2023 | 15 | 2023 |
| Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections H Chemaitelly, HH Ayoub, S AlMukdad, JS Faust, P Tang, P Coyle, ... Journal of Travel Medicine 30 (5), taad106, 2023 | 12 | 2023 |
| Epidemiology of herpes simplex virus type 1 and genital herpes in Australia and New Zealand: Systematic review, meta-analyses and meta-regressions S AlMukdad, M Harfouche, US Farooqui, L Aldos, LJ Abu-Raddad Epidemiology & Infection 151, e33, 2023 | 12 | 2023 |
| Exploring the role of community pharmacists in obesity and weight management in Qatar: a mixed-methods study S AlMukdad, N Zaghloul, A Awaisu, ZR Mahfoud, N Kheir, MS El Hajj Risk Management and Healthcare Policy, 2771-2787, 2021 | 11 | 2021 |
| Epidemiology of herpes simplex virus type 2 in Canada, Australia, and New Zealand: systematic review, meta-analyses, and meta-regressions S AlMukdad, US Farooqui, M Harfouche, L Aldos, LJ Abu-Raddad Sexually Transmitted Diseases 49 (6), 403-413, 2022 | 10 | 2022 |
